Cargando…

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy

Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Claire, Traynor, Carol, O'Kelly, Patrick, Dorman, Anthony, Conlon, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600182/
https://www.ncbi.nlm.nih.gov/pubmed/23533756
http://dx.doi.org/10.1155/2013/818537
_version_ 1782475599819833344
author Kennedy, Claire
Traynor, Carol
O'Kelly, Patrick
Dorman, Anthony
Conlon, Peter J.
author_facet Kennedy, Claire
Traynor, Carol
O'Kelly, Patrick
Dorman, Anthony
Conlon, Peter J.
author_sort Kennedy, Claire
collection PubMed
description Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease recurrence and to identify factors associated with disease recurrence. Methods. We accessed the Irish renal transplant database to identify patients with biopsy-proven idiopathic membranous nephropathy in receipt of a renal transplant between 1982 and 2010. A detailed medical chart review was performed in all cases, and a senior renal histopathologist reviewed all histology specimens. Results. The outcomes of 32 patients, in receipt of 36 grafts, are reported. There was a male preponderance (n = 29). Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. There was no significant association between time on dialysis, HLA mismatch, occurrence of rejection, and the development of recurrent membranous disease. One patient was retransplanted twice; all three grafts were lost to aggressive recurrent membranous disease. Conclusions. It remains difficult to identify those that will develop recurrent membranous nephropathy. Almost one third of patients in this cohort developed clinically significant recurrent disease at 10 years.
format Online
Article
Text
id pubmed-3600182
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36001822013-03-26 Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy Kennedy, Claire Traynor, Carol O'Kelly, Patrick Dorman, Anthony Conlon, Peter J. Int J Nephrol Research Article Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease recurrence and to identify factors associated with disease recurrence. Methods. We accessed the Irish renal transplant database to identify patients with biopsy-proven idiopathic membranous nephropathy in receipt of a renal transplant between 1982 and 2010. A detailed medical chart review was performed in all cases, and a senior renal histopathologist reviewed all histology specimens. Results. The outcomes of 32 patients, in receipt of 36 grafts, are reported. There was a male preponderance (n = 29). Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. There was no significant association between time on dialysis, HLA mismatch, occurrence of rejection, and the development of recurrent membranous disease. One patient was retransplanted twice; all three grafts were lost to aggressive recurrent membranous disease. Conclusions. It remains difficult to identify those that will develop recurrent membranous nephropathy. Almost one third of patients in this cohort developed clinically significant recurrent disease at 10 years. Hindawi Publishing Corporation 2013 2013-02-27 /pmc/articles/PMC3600182/ /pubmed/23533756 http://dx.doi.org/10.1155/2013/818537 Text en Copyright © 2013 Claire Kennedy et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kennedy, Claire
Traynor, Carol
O'Kelly, Patrick
Dorman, Anthony
Conlon, Peter J.
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_full Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_fullStr Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_full_unstemmed Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_short Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_sort transplant outcomes in patients with idiopathic membranous nephropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600182/
https://www.ncbi.nlm.nih.gov/pubmed/23533756
http://dx.doi.org/10.1155/2013/818537
work_keys_str_mv AT kennedyclaire transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT traynorcarol transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT okellypatrick transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT dormananthony transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT conlonpeterj transplantoutcomesinpatientswithidiopathicmembranousnephropathy